Private Equity and the One Big Beautiful Bill Act: Opportunities and Challenges
Expanded QSBS Exclusion, Relaxation of Limitation on Interest Deductions, Expanded Bonus Depreciation, and More
Recording of a 90-minute premium CLE video webinar with Q&A
This CLE webinar will address the One Big Beautiful Bill Act's (OBBBA or Act) impact on private equity. The panel will highlight the key tax provisions of OBBBA impacting private equity funds, investors, and portfolio companies as well as notable proposals not included in the final Act. The panel will also provide guidance on navigating these changes and requirements going forward.
Outline
- Introduction: OBBBA overview and history
- OBBBA's implications for private equity funds, investors, and portfolio companies
- Enhanced QSBS benefits under Section 1202
- Relaxed limitation on deductibility of business interest under Section 163(j)
- Permanent qualified business income deduction under Section 199A
- Expansion of bonus depreciation benefits
- Changes implicating cross-border M&A
- Other changes potentially impacting private equity
- Notable provisions excluded from the final Act
- Taxation of carried interest
- Preferential capital gains tax rate
- Retaliatory tax on certain foreign investors
- Best practices for guiding clients on the new requirements
Benefits
The panel will discuss these and other key considerations:
- What OBBBA provisions impact private equity, and what opportunities and challenges do they present?
- What notable tax provisions relevant to private equity remained unchanged with the recent legislation?
- What are the practical implications of OBBBA on private equity business strategies and investments?
- How can private equity funds, investors, and portfolio companies take advantage of OBBBA's new tax regime?
Faculty

Alex Farr
Partner
Paul Hastings
Mr. Farr focuses his practice on federal income and international tax planning for partnerships, corporations, and... | Read More
Mr. Farr focuses his practice on federal income and international tax planning for partnerships, corporations, and individuals related to complex domestic and international business transactions across a variety of industries, including the technology, healthcare, real estate, and energy sectors. He advises private equity funds, portfolio companies, and public companies with respect to strategic mergers, acquisitions, and reorganizations. Mr. Farr has significant experience with investment fund formation and structuring matters, advising both fund sponsors and limited partner investors. He has extensive experience advising single family offices and high net worth clients with respect to both strategic internal tax structuring and M&A transactional matters across a number of industries, including sports and entertainment, hospitality, technology, and others.
Close
Lucas M. Rachuba
Partner
Paul Hastings
Mr. Rachuba focuses on private equity and public company M&A, credit funds, hedge funds, venture capital and... | Read More
Mr. Rachuba focuses on private equity and public company M&A, credit funds, hedge funds, venture capital and real estate transactions. His clients include private equity firms, portfolio companies, public companies and stand-alone fund clients. Mr. Rachuba works with private equity principals, boards of directors and members of senior management. He also advises on various topics related to transaction and fund structuring, including on international issues, taxation of carried interests, QSBS and tax elements of compensation structuring.
Close
Sherry Xie
Partner
Paul Hastings
Ms. Xie advises U.S. and international clients, both public and private, on a broad range of tax matters,... | Read More
Ms. Xie advises U.S. and international clients, both public and private, on a broad range of tax matters, including the tax aspects of mergers, acquisitions, reorganizations and other complex business transactions. She routinely represents leading public corporations and private equity firms and their portfolio companies across multiple industries, including consumer products, technology, healthcare, manufacturing and financial services.
Close